Deubiquitinases in cancer

G Dewson, PJA Eichhorn, D Komander - Nature Reviews Cancer, 2023 - nature.com
Ubiquitination is an essential regulator of most, if not all, signalling pathways, and defects in
cellular signalling are central to cancer initiation, progression and, eventually, metastasis …

Ubiquitin–proteasome system as a target for anticancer treatment—an update

YJ Kim, Y Lee, H Shin, SA Hwang, J Park… - Archives of pharmacal …, 2023 - Springer
As the ubiquitin–proteasome system (UPS) regulates almost every biological process, the
dysregulation or aberrant expression of the UPS components causes many pathological …

O-GlcNAcylation of Raptor transduces glucose signals to mTORC1

C Xu, X Pan, D Wang, Y Guan, W Yang, X Chen, Y Liu - Molecular Cell, 2023 - cell.com
The mechanistic target of rapamycin complex 1 (mTORC1) regulates metabolism and cell
growth in response to nutrient levels. Dysregulation of mTORC1 results in a broad spectrum …

Targeting mTOR as a cancer therapy: Recent advances in natural bioactive compounds and immunotherapy

A Bouyahya, A El Allam, S Aboulaghras, S Bakrim… - Cancers, 2022 - mdpi.com
The mammalian target of rapamycin (mTOR) is a highly conserved serine/threonine-protein
kinase, which regulates many biological processes related to metabolism, cancer, immune …

[HTML][HTML] Targeting ferroptosis by ubiquitin system enzymes: a potential therapeutic strategy in cancer

Y Meng, H Sun, Y Li, S Zhao, J Su, F Zeng… - … Journal of Biological …, 2022 - ncbi.nlm.nih.gov
Ferroptosis is a novel type of regulated cell death driven by the excessive accumulation of
iron-dependent lipid peroxidation. Therapy-resistant tumor cells, particularly those in the …

Role of O-linked N-acetylglucosamine protein modification in oxidative stress-induced autophagy: a novel target for bone remodeling

S Li, W Ren, J Zheng, S Li, K Zhi, L Gao - Cell Communication and …, 2024 - Springer
O-linked N-acetylglucosamine protein modification (O-GlcNAcylation) is a dynamic post-
translational modification (PTM) involving the covalent binding of serine and/or threonine …

The HACE1 E3 ligase mediates RAC1‐dependent control of mTOR signaling complexes

B Turgu, A El‐Naggar, M Kogler, L Tortola… - EMBO …, 2023 - embopress.org
HACE1 is a HECT family E3 ubiquitin–protein ligase with broad but incompletely understood
tumor suppressor activity. Here, we report a previously unrecognized link between HACE1 …

Phosphorylation-dependent deubiquitinase OTUD3 regulates YY1 stability and promotes colorectal cancer progression

L Wu, Z Zhou, Y Yu, C Cheng, S Zhou, Y Yan… - Cell Death & …, 2024 - nature.com
Abstract Yin Yang 1 (YY1) is a key transcription factor that has been implicated in the
development of several malignancies. The stability of YY1 is regulated by the ubiquitin …

Cellular and molecular events in colorectal cancer: biological mechanisms, cell death pathways, drug resistance and signalling network interactions

L Yan, J Shi, J Zhu - Discover Oncology, 2024 - Springer
Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide, affecting
millions each year. It emerges from the colon or rectum, parts of the digestive system, and is …

[HTML][HTML] GATOR2-dependent mTORC1 activity is a therapeutic vulnerability in FOXO1 fusion–positive rhabdomyosarcoma

J Morales, DV Allegakoen, JA Garcia, K Kwong… - JCI insight, 2022 - ncbi.nlm.nih.gov
Oncogenic FOXO1 gene fusions drive a subset of rhabdomyosarcoma (RMS) with poor
survival; to date, these cancer drivers are therapeutically intractable. To identify new …